Standout Papers

Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a mul... 2019 2026 2021 2023 218
  1. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial (2019)
    Gregory L. Krauss, Pavel Klein et al. The Lancet Neurology

Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Persistent physical symptoms: definition, genesis, and management
2024 Standout
New epilepsy therapies in development
2024 Standout
16 intermediate papers

Works of Ivan Milanov being referenced

Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials
2022
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
2019 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Ivan Milanov 622 695 384 623 90 2.1k
George W. Paulson 1165 506 515 302 127 2.5k
Paolo Aridon 945 973 466 595 69 2.9k
G D’Andrea 380 1404 271 851 150 3.1k
Charles Murchison 662 253 722 403 73 2.6k
Letizia Maria Cupini 462 1024 257 490 58 2.5k
Marco D’Amelio 1338 705 538 374 87 2.9k
Eduardo Caverzasi 406 893 255 288 75 3.1k
Louis Vallée 400 855 482 345 148 2.8k
Alfredo Damasceno 397 423 245 648 91 1.9k
Francesca Caramia 489 512 268 867 74 2.3k

All Works

Loading papers...

Rankless by CCL
2026